ArgenTag logo β€” Enabling single cell sequencing for anyone, anywhere 🧬

ArgenTag

Enabling single cell sequencing for anyone, anywhere 🧬

Founded 2021 United States United States 10 employees Pre-Seed Biotechnology, Clean Energy

General Information

Company Name ArgenTag
Founded Year 2021
Location United States United States
Employees 10
Industries Biotechnology, Clean Energy
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with ArgenTag. To contact ArgenTag, visit argentag.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ArgenTag

ArgenTag is a biotechnology and clean energy startup founded in 2021, with a mission to enable single-cell sequencing for anyone, anywhere. Based in the United States, the company recently received a Pre Seed Round investment on 03 April 2023 from notable investors including Draper Cygnus and AIR Capital. With a focus on democratizing access to single-cell sequencing technology, ArgenTag is positioned to make significant strides in the biotechnology and clean energy sectors.

Taxonomy: Biotech, Genomic Sequencing, Long-read Sequencers, Molecular Tracking, Next Generation Sequencing, Oxford Nanopore Technologies, Pacific Biosciences, Barcoding, Multiplexing, Single-cell, Metagenomics, Proprietary Technology, Startup, Democratization of Sequencing, Innovation

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 2
Draper Cygnus, AIR Capital
03 Apr 2023
Convertible Note Undisclosed -
08 Feb 2022
Pre Seed Round Undisclosed 1
Draper University Ventures
23 Jun 2021
Pre Seed Round Undisclosed 1
GRIDX
02 Mar 2021
Grant Undisclosed -
01 Jul 2019

ArgenTag Alternatives & Competitors

ArgenTag vs
Macrogen Europe
Macrogen Europe The Netherlands

Committed to Sequencing Excellence

71 employees
Biotechnology, Health Care
ArgenTag vs
Parse Biosciences
Parse Biosciences United States

Scalable Single Cell Sequencing Without the Instrument

Acquired
133 employees
Biotechnology, Life Sciences

FAQ About ArgenTag

Enabling single cell sequencing for anyone, anywhere 🧬
ArgenTag was founded in 2021.
ArgenTag is headquartered in United States.
ArgenTag operates in Biotechnology and Clean Energy. Its work centres on Biotech, Genomic Sequencing, Long-read Sequencers and Molecular Tracking.
ArgenTag has approximately 10 employees.
ArgenTag has completed 5 funding rounds. The latest funding stage is Pre-Seed.
Top alternatives and competitors to ArgenTag include Macrogen Europe, Parse Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ArgenTag and Macrogen Europe are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ArgenTag, https://bouncewatch.com/company/argentag, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes